Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Candidate tumor supressor.. Zusätzlich bieten wir Ihnen und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 17 products:
Human Polyclonal DEC1 Primary Antibody für ICC, IF - ABIN151308
Ralph, Parham, Lee, Beard, Craigon, Ward, White, Barber, Rayner, Kingsman, Mundy, Mazarakis, Krige: Identification of potential stroke targets by lentiviral vector mediated overexpression of HIF-1 alpha and HIF-2 alpha in a primary neuronal model of hypoxia. in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2004
Show all 14 Pubmed References
Human Polyclonal DEC1 Primary Antibody für IHC (p), WB - ABIN4304698
Donninger, Calvisi, Barnoud, Clark, Schmidt, Vos, Clark: NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2. in The Journal of cell biology 2015
These results provide evidence that DEC1 and DEC2 have opposite effects on TGFbetainduced epithelialmesenchymal transition in human prostate cancer PC3 cells.
DEC1 acts as an anti-apoptotic regulator in gastric cancer cells under hypoxia by promoting Survivin expression.
DEC1 is down-regulated and tends to contribute to the migration ability of tumor cell lines; H3 K27 trimethylation potentially plays an important role in the regulation of DEC1 expression
DEC1 promoter -249 T>C (rs2012775) polymorphism is functional, modulating susceptibility to squamous cell carcinoma of the head and neck (SCCHN) among non-Hispanic Whites.
DEC1 is a candidate tumor suppressor gene that may be involved in esophageal squamous cell carcinoma development
Decreased expression of candidate DEC1 is associated with esophageal carcinoma
Candidate tumor supressor.
candidate tumor suppressor CTS9
, deleted in esophageal cancer 1